Xentuzumab (Synonyms: BI 836845; Anti-Human IGF1 and IGF2 Recombinant Antibody) |
Catalog No.GC70151 |
Xentuzumab (anticorps recombinant anti-IGF1 et IGF2 humains ; BI836845) est un anticorps monoclonal humanisé ciblant les ligands IGF1 et IGF2 de l'IGF. Xentuzumab inhibe les signaux de croissance stimulants d'IGF1 et d'IGF2, ainsi que l'activation d'AKT.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1417158-65-6
Sample solution is provided at 25 µL, 10mM.
Review for Xentuzumab
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)Review for Xentuzumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *